首页 | 本学科首页   官方微博 | 高级检索  
     

血管加压素1a与血管加压素2受体在精氨加压素调节缺氧血管平滑肌细胞蛋白激酶C表达中的作用
引用本文:杨光明,徐竞,李涛,明佳,陈玮,刘良明. 血管加压素1a与血管加压素2受体在精氨加压素调节缺氧血管平滑肌细胞蛋白激酶C表达中的作用[J]. 中国药理学与毒理学杂志, 2009, 23(1): 29-33. DOI: 10.3867/j.issn.1000-3002.2009.01.006
作者姓名:杨光明  徐竞  李涛  明佳  陈玮  刘良明
作者单位:第三军医大学大坪医院野战外科研究所第二研究室,创伤烧伤与复合伤国家重点实验室,重庆,400042
基金项目:国家杰出青年科学基金,国家重点基础研究发展规划(973计划),教育部创新团队资助计划 
摘    要:目的观察血管加压素1a(V1a)受体与V2受体拮抗剂对精氨加压素(AVP)调节缺氧血管平滑肌细胞(VSMC)蛋白激酶C(PKC)α,δ和ε亚型表达的影响,以及磷脂酶C(PLC)、磷脂酶D(PLD)和磷脂酶A2(PLA2)活性的变化。方法缺氧培养大鼠肠系膜上动脉VSMC,采用Western蛋白印迹法检测PKCα,δ和ε亚型蛋白表达;采用酶偶联荧光分析法测定PLC和PLD的活性,酸碱滴定法检测PLA2的活性。结果缺氧处理1.5h,VSMC胞膜PKC-α和ε亚型蛋白表达量明显升高,AVP进一步升高胞膜PKC-α和ε的表达。V1a受体拮抗剂d(CH2)5[Tyr2(Me)]AVP预处理可明显拮抗AVP诱导的胞膜PKCα和ε亚型蛋白表达升高,同时也明显拮抗AVP诱导的缺氧VSMC中PLC和PLD活性升高。而V2受体拮抗剂d(CH2)[d-Ile2Abu4]AVP对缺氧诱导的胞膜PKC-α和ε表达增加和VSMC中PLC和PLD活性升高无明显作用。结论AVP诱导PKC激活的机制可能与V1a受体介导的PLC/PLD途径有关,而V2受体在这一信号传导途径中可能并不起主要作用。

关 键 词:受体,血管加压素  血管平滑肌细胞  缺氧  精氨加压素  蛋白激酶C  磷脂酶C  磷脂酶D  磷脂酶A2
收稿时间:2008-07-14

Vasopressin-1a and vasopressin-2 receptors in argipressin regulating expression of protein kinase C of vascular smooth muscle cell after hypoxia
YANG Guang-Ming,XU Jing,LI Tao,MING Jia,CHEN Wei,LIU Liang-Ming. Vasopressin-1a and vasopressin-2 receptors in argipressin regulating expression of protein kinase C of vascular smooth muscle cell after hypoxia[J]. Chinese Journal of Pharmacology and Toxicology, 2009, 23(1): 29-33. DOI: 10.3867/j.issn.1000-3002.2009.01.006
Authors:YANG Guang-Ming  XU Jing  LI Tao  MING Jia  CHEN Wei  LIU Liang-Ming
Affiliation:(State Key Laboratory of Trauma, Burns and Combined Injury, Research Institute of Surgery, Daping Hospital, the Third Military Medical University, Chongqing 400042, China)
Abstract:AIM To investigate the effects of vasopressin-1a(V1a) receptor and V2 receptor antagonists on argipressin (AVP) regulating the expression of protein kinase C (PKC)-α, δ and ε isoforms of vascular smooth muscle cell (VSMC) and the changes in phospholipases C (PLC), D (PLD) and A2 (PLA2) activity. METHODS VSMCs from superior mesenteric artery of rats were hypoxia-treated for 1.5 h. The expression of PKC-α, δ and ε isoforms was detected with Western blot. The PLC and PLD activities were assayed by enzyme-coupled fluorimetric analysis, and PLA2 activity was assayed by acid-base titration. RESULTS After hypoxia, the expression of VSMC particulate PKC-α and ε increased, and AVP treatment further increased expression of PKC-α and ε in the particulate fractions. V1aReceptor inhibitor d(CH2)5[Tyr2(Me)]AVP significantly antagonized this effect of AVP, simultaneously, also antagonized AVP-induced increase in PLC and PLD activities of VSMC after hypoxia. But V2 receptor antagonist d(CH2)[d-Ile2Abu4]AVP had no significant influence on AVP-induced increase in expression of PKC-α and ε isoforms and the activities of PLC and PLD. CONCLUSION AVP induces translocation/activation of PKC isoforms in VSMC mainly through a V1a receptor-dependent PLC/PLD mechanism, while V2 receptor plays a lesser role in the signal transduction pathway.
Keywords:receptors  vasopressin  vascular smooth muscle cell  hypoxia  argipressin  protein kinase C  phospholipase C  phospholipase D  phospholipase A2
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《中国药理学与毒理学杂志》浏览原始摘要信息
点击此处可从《中国药理学与毒理学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号